SEC Form 4 · accession 0001209191-16-125311
Tracon Pharmaceuticals, Inc. · TCON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin A Mattingly
Director
Period of report
Jun 1, 2016
Accepted (ET)
Jun 2, 2016 · 7:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001394319
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2016 | A | 7,500 | $0.00 | A | 7,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2015 Equity Incentive Plan. The RSUs will vest in full on the earlier of the one-year anniversary of the date of grant, or the date of the next annual meeting of the Company's stockholders.